Ainos (AIMD) news
Recent news
Ainos - Total license fees payable to Ainos could reach $10 mln if all indications licensed - SEC filing
Ainos Inc. (NASDAQ: AIMD) has disclosed in a recent SEC filing that license fees could reach $10 million if all indications under its licensing agreements are pursued. The information was included in the company’s ongoing regulatory disclosures, which outline financial and operational developments.…
AInvest Wire · Sep 28, 2026Ainos - Biophoenix to pay Ainos upfront license fee of $600,000 - SEC filing
Ainos, Inc. (NASDAQ:AIMD) has entered into a licensing agreement with BioPhoenix Co., Ltd. under which the latter will pay an upfront license fee of $600,000 to Ainos for the exclusive rights to develop and commercialize VELDONA® for two initial indications: Sjögren’s disease and thrombocytopenia.…
AInvest Wire · Sep 28, 2026Ainos - Enters global exclusive license agreement with Biophoenix on Sept 24, 2026 - SEC filing
Ainos Inc. (NASDAQ: ANOS) has entered into a global exclusive license agreement with Biophoenix, a biotechnology firm, as disclosed in a recent SEC filing [1]. The agreement, effective September 24, 2026, grants Ainos exclusive rights to develop, manufacture, and commercialize a proprietary…
AInvest Wire · Sep 28, 2026Ainos - enters credit lines agreement with CTBC Bank on July 3, 2026 - SEC filing
Ainos Inc. has entered into a credit lines agreement with CTBC Bank, as disclosed in a recent SEC filing dated July 3, 2026. The agreement outlines the terms of the credit facility, which is intended to support the company’s operational and strategic financial needs. The filing, submitted under the…
AInvest Wire · Jul 9, 2026Ainos - credit facility matures on September 30, 2026 - SEC filing
AInvest Wire · Jul 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.